FindTrial
Sign In

A CLINICAL TRIAL OF MURCHHITA GO GHRITA AND SHATAVARI GHRITA IN INTERNAL OLEATION THERAPY IN HYPER-ACIDITY.

A COMPARATIVE CLINICAL STUDY OF SNEHAN KARMA WITH MURCHHITA GO GHRITA AND SHATAVARI GHRITA IN URDHWAGA AMLAPITTA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030099
Enrollment
40
Registered
2020-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis Health Condition 2: K296- Other gastritis

Interventions

Intervention1: MURCHHITA GO GHRITA: TO KNOW THE EFFECT OF MURCHHITA GO GHRITA AS SHODHANAGA SNEHPANA IN URDHWAGA AMLAPITTA. Intervention2: SHATAVARI GHRITA: 20 PATIENTS WILL BE ADMINISTERED UNDER SHO

Sponsors

PARUL INSTITUTE OF AYURVED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients indicated for Snehapana. 2) Age group between 18-60 years. 3) Patient having the classical sign & symptoms of Urdhwaga Amlapitta 4)Patien t indicated for Vaman

Exclusion criteria

Exclusion criteria: 1) Patients contraindicated for Snehapana and Vamana. 2) Urdhwaga Amlapitta associated with other systemic disorder-Diabetes mellitus, Hypertension, Carcinoma, Tuberculosis, Infectious diseases, Pregnant Women and other life threatening disorders. 3) Known Patients of Gastric or Duodenal ulcer or with its complications, Gastric Carcinoma will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
EFFICACY OF SHODHANANG SNEHAPAN WITH MURCHHITA GO-GHRITA IN URDHWAGA AMLAPITTATimepoint: 15 DAYS—

Secondary

MeasureTime frame
EFFICACY OF SHODHANANG SNEHAPAN WITH SHATAVARI GHRITA IN URDHWAGA AMLAPITTATimepoint: 15 DAYS—

Countries

India

Contacts

Public ContactDR DINESH B PATIL

PARUL INSTITUTE OF AYURVED

dr.dineshpatil3@gmail.com9039764509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026